Home
Resources
Diseases
Training
SYSVAC
About
Registry
E-learning courses
News
Events
Network
Vision and Mission
Steering Committee
Map
Meetings
Join us
Home
Resources
Resources
Selected
COVID-19
Haemophilus influenzae type B
2022
2019
Western Pacific
Clear all
Type of publications
NITAG documentation
(11)
Systematic reviews (SYSVAC)
(7)
Topics
Available to download in languages
Regions
Western Pacific
(18)
Africa
(28)
Americas
(41)
Eastern Mediterranean
(3)
Europe
(34)
South-East Asia
(2)
Countries
Australia
(11)
China
(6)
Diseases
COVID-19
(17)
Haemophilus influenzae type B
(1)
Diphtheria
(1)
Hepatitis B
(4)
Human papillomavirus (HPV)
(5)
Influenza
(3)
Japanese encephalitis
(1)
Meningococcal disease
(1)
Mpox // Monkeypox
(1)
Pertussis
(1)
Pneumococcal disease
(4)
Poliomyelitis
(1)
Tetanus
(1)
Tuberculosis
(1)
Vaccine topics
Acceptance
(3)
Administration
(1)
Economic aspects
(1)
Efficacy/effectiveness
(2)
Safety
(2)
Target population
Adolescents
(2)
Adults
(5)
All age groups
(1)
Children
(3)
Healthcare workers
(1)
Newborn
(1)
Older adults
(2)
Parents/caregivers
(1)
Publication date
2022
(17)
2019
(1)
2023
(5)
2021
(14)
2020
(19)
2017
(1)
2015
(1)
2013
(2)
18 results found
2022
∙
Xu, B. Zhu, Y.
A systematic review and meta-analysis of the factors associating the willingness of Chinese community residents to receive COVID-19 vaccine
2022
∙
Ma, Y. Ren, J. Zheng, Y. Cai, D. Li, S. Li, Y.
Chinese parents' willingness to vaccinate their children against COVID-19: A systematic review and meta-analysis
2022
∙
Chen, Z. Peng, Y. Wu, X. Pang, B. Yang, F. Zheng, W. Liu, C. Zhang, J.
Comorbidities and complications of COVID-19 associated with disease severity, progression, and mortality in China with centralized isolation and hospitalization: A systematic review and meta-analysis
2022
∙
Shui, X. Wang, F. Li, L. Liang, Q.
COVID-19 vaccine acceptance among healthcare workers in China: A systematic review and meta-analysis
2022
∙
Fu, Y. Zhao, J. Wei, X. Han, P. Yang, L. Ren, T. Zhan, S. Li, L.
Effectiveness and Cost-Effectiveness of Inactivated Vaccine to Address COVID-19 Pandemic in China: Evidence From Randomized Control Trials and Real-World Studies
2022
∙
Chen, H. Zhang, X. Lin, G. Gong, F. Hocher, B.
Safety of COVID-19 vaccination in women undergoing IVF/ICSI treatment - Clinical study and systematic review
2022
∙
ATAGI
ATAGI recommendations on use of the Pfizer bivalent (Original/Omicron BA.1) COVID-19 vaccine
2022
∙
ATAGI
ATAGI recommendations for a booster dose of the paediatric Pfizer COVID-19 vaccine in children aged 5 to 11 years
2022
∙
ATAGI
COVID-19 vaccination – Guidance on myocarditis and pericarditis after COVID-19 vaccines
2022
∙
ATAGI
ATAGI statement on use of the Moderna bivalent Original/Omicron vaccine
Home
Resources
Diseases
Training
SYSVAC
News
Events
Network
Sign in / Register